Ozempic prescribing information, Food and Drug Administration (2025) Mounjaro prescribing information, Food and Drug Administration (2025) FDA approves Ozempic (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease, Novo Nordisk USA (2025) Check your cost and coverage, NovoCare Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Published example listings: Earlier reporting on retatrutide pricing has highlighted very different online examples, including a 30 mg vial, a 20 mg vial, and even laboratory catalog pricing for much smaller quantities
To dissolve this issue different studies have been undertaken in order to estimate the prevalence of MetS
doi: 10.1016/j.bcp.2023.115446 67 WangTCaiBDingMSuZLiuYShenL
Warnings and Precautions Not for type 1 diabetes or diabetic ketoacidosis Avoid in patients with history of medullary thyroid cancer or MEN 2 syndrome Caution in severe gastrointestinal disease or history of pancreatitis May delay absorption of oral medications Not recommended during pregnancy or breastfeeding Stay hydrated, especially during initial treatment Alternative Medications (by Indication) For type 2 diabetes or weight loss: Mounjaro (tirzepatide) dual GLP-1/GIP agonist Rybelsus (oral semaglutide) daily pill Trulicity (dulaglutide) weekly GLP-1 injection Victoza (liraglutide) daily GLP-1 injection Wegovy (semaglutide) higher-dose version for weight loss Metformin oral glucose control Insulin therapies for advanced cases Medication FAQs Ozempic (semaglutide) Is Ozempic insulin
And the off-label extras you might be counting on, the heart data especially, belong to semaglutide, not to the new pill